A Review of Applications of Metabolomics in Cancer

被引:203
作者
Beger, Richard D. [1 ]
机构
[1] US FDA, Natl Ctr Toxicol Res, 3900 NCTR Rd, Jefferson, AR 72079 USA
关键词
cancer; metabolomics; metabonomics; personalized medicine; biomarker;
D O I
10.3390/metabo3030552
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is a devastating disease that alters the metabolism of a cell and the surrounding milieu. Metabolomics is a growing and powerful technology capable of detecting hundreds to thousands of metabolites in tissues and biofluids. The recent advances in metabolomics technologies have enabled a deeper investigation into the metabolism of cancer and a better understanding of how cancer cells use glycolysis, known as the "Warburg effect," advantageously to produce the amino acids, nucleotides and lipids necessary for tumor proliferation and vascularization. Currently, metabolomics research is being used to discover diagnostic cancer biomarkers in the clinic, to better understand its complex heterogeneous nature, to discover pathways involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide clues to personalized cancer treatments by providing useful information to the clinician about the cancer patient's response to medical interventions.
引用
收藏
页码:552 / 574
页数:23
相关论文
共 156 条
[1]  
Ackerstaff E, 2001, CANCER RES, V61, P3599
[2]   Improving Proton MR Spectroscopy of Brain Tissue for Noninvasive Diagnostics [J].
Alusta, Pierre ;
Im, Inessa ;
Pearc, Bruce A. ;
Beger, Richard D. ;
Kretzer, Ryan M. ;
Buzatu, Dan A. ;
Wilkes, Jon G. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2010, 32 (04) :818-829
[3]  
[Anonymous], 2006, GUID IND PHARM DAT S
[4]   Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine [J].
Backshall, Alexandra ;
Sharma, Rohini ;
Clarke, Stephen J. ;
Keun, Hector C. .
CLINICAL CANCER RESEARCH, 2011, 17 (09) :3019-3028
[5]   Identification of Biological Tissues by Rapid Evaporative Ionization Mass Spectrometry [J].
Balog, Julia ;
Szaniszlo, Tamas ;
Schaefer, Karl-Christian ;
Denes, Julia ;
Lopata, Antal ;
Godorhazy, Lajos ;
Szalay, Daniel ;
Balogh, Lajos ;
Sasi-Szabo, Laszlo ;
Toth, Mikos ;
Takats, Zoltan .
ANALYTICAL CHEMISTRY, 2010, 82 (17) :7343-7350
[6]   Proton (1H) MR spectroscopy of the breast [J].
Bartella, Lia ;
Huang, Wei .
RADIOGRAPHICS, 2007, 27 :S241-S252
[7]   Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses [J].
Bayet-Robert, Mathilde ;
Morvan, Daniel ;
Chollet, Philippe ;
Barthomeuf, Chantal .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (03) :613-626
[8]   Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma [J].
Beger, Richard D. ;
Schnackenberg, Laura K. ;
Holland, Ricky D. ;
Li, Donghui ;
Dragan, Yvonne .
METABOLOMICS, 2006, 2 (03) :125-134
[9]   Metabolomics data and the biomarker qualification process [J].
Beger, Richard D. ;
Colatsky, Thomas .
METABOLOMICS, 2012, 8 (01) :2-7
[10]   Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice [J].
Beger, Richard D. ;
Hansen, Deborah K. ;
Schnackenberg, Laura K. ;
Cross, Brandie M. ;
Fatollahi, Javad J. ;
Lagunero, F. Tracy ;
Sarnyai, Zoltan ;
Boros, Laszlo G. .
METABOLOMICS, 2009, 5 (03) :336-345